Supplier Management

Dear Sir or Madam,

I am delighted to be able to present to you the first RHÖN-KLINIKUM AG progress report.

Innovation and progress are two of our corporate strategy’s most important focal points. That makes us one of the most pioneering healthcare companies in Germany; at the same time, we also intend to actively deepen the trust our patients put in our services even further.

Trust is a sensitive yet also important asset. It grows with every experience of the excellent medical treatment and care provided at at our facilities. However, trust is also encouraged by talking openly about the company’s services. That is what this progress report is all about: we want to become even more transparent to our patients and partners. At the same time, we want to live up to our stakeholders’ increased expectations regarding information. We also want to communicate the sustainability of our corporate decisions even more clearly.

For example, hospitals inherently consume a lot of energy. We can therefore justifiably be expected to address this fact in a focused and critical way. We are also driving a number of construction projects forward. In this respect, the efficient use of resources is again an ongoing challenge.

However, operating sustainably also means taking one’s social responsibilities seriously. This progress report is therefore also something of a roadmap: only a sober review of the progress that has been made, as well as of shortcomings, can provide proper guidance for further sustainable corporate development.

The contents of this progress report are largely based on the exacting guidelines of the Global Reporting Initiative (GRI). Nevertheless, we do not consider this first report to be conclusive and complete. The initial focus was on reviewing the current situation, rather than on scrupulously detailing and documenting the key figures. In future, we intend to systematically extend the reporting to allow this progress report to be developed further into a purposeful sustainability report published on an annual basis.

Of course, we also view this publication as a way of initiating dialogue. It is directed at our patients, staff and business partners, but also at investors, and representatives from the areas of politics and academia. We always welcome suggestions and constructive criticism.


Dr. med. Dr. jur. Martin Siebert
Chairman of the Board of Management